Riskpilot← Back to searchSign inGet full accessMARINE BIO SOLUTIONS AS
ASActiveOrg 915622070Liv-Bygget Verkstedveien 4, 7125 VanvikanSupport activities for fishing and aquaculture · NACE 0330Est. 20150 employees
Revenue 2024
NOK 93K
EBITDA margin
-358.2%
-8% vs 2023
Equity ratio
-29.8%
Financial strength
Net profit 2024
NOK -519K
-86% vs 2023
| Revenue | NOK 93K | — |
| EBITDA | NOK -334K | -8% |
| Net profit | NOK -519K | -86% |
| Total assets | NOK 1,4M | -5% |
| Equity | NOK -417K | -509% |
| Employees | 0 | — |
Legal name
MARINE BIO SOLUTIONS AS
Org number
915622070
Legal form
Aksjeselskap
NACE code
0330 · Support activities for fishing and aquaculture
Founded
3. juli 2015
Share capital
NOK 440 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Utvikle, produsere og markedsføre løsninger relatert til akvakultur og annen biologisk produksjon, samt annen virksomhet som står i denne forbindelse.
Address
Liv-Bygget Verkstedveien 4, 7125 Vanvikan
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 138 | 1 525 | 25 | 0 | 93 |
| Staff expenses | −0 | −544 | −0 | −0 | −0 |
| EBITDA | −26 | 30 | −227 | −311 | −334 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −240 |
| EBIT | −26 | 30 | −227 | −311 | −574 |
| Net financials | 1 | −0 | −14 | −48 | −91 |
| Profit before tax | −25 | 29 | −242 | −358 | −665 |
| Tax | −6 | 6 | −53 | −79 | −146 |
| Net profit | −20 | 23 | −188 | −279 | −519 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 677 | 1 005 | 1 342 | 1 478 | 1 401 |
| Equity | 547 | 570 | 381 | 102 | −417 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 033 | 338 | 863 | 1 279 | 1 740 |
| Total debt | 1 033 | 338 | 863 | 1 279 | 1 740 |
EBITDA margin
-358.2%
This company
15.8%
Market median
-2367% vs market
20202024
Equity ratio
-29.8%
This company
38.2%
Market median
-178% vs market
20202024
Return on equity
-51876700.0%
This company
18.4%
Market median
-281938687% vs market
20202024
Net profit margin
-555.9%
This company
8.1%
Market median
-6963% vs market
20202024
Asset turnover
0.07×
This company
1.12×
Market median
-94% vs market
20202024
Debt / equity
4.36×
This company
0.62×
Market median
-603% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2017 | |
| Board of Directors | 2017 | |
| Board of Directors | 2017 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 60% | 60% | 2022 | |
| Individual | 21% | 21% | 2022 | |
| Company | 19% | 19% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MARINE BIO SOLUTIONS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Håvard Wollan | Chairman | 0 companies |
| Stein Wold Østerhus | Board of Directors | 0 companies |
| Ole Laurits Haugen | Board of Directors | 0 companies |